A Review of Male Sexual Health and Dysfunction Following Surgical Treatment for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
- 74 Downloads
Purpose of Review
Review how the various surgical treatments for benign prostatic hyperplasia and lower urinary tract symptoms impact on male sexual health and function.
The interplay between benign prostatic hyperplasia and erectile function is complex, and the conditions seem linked. Most cavitating procedures to improve male voiding will degrade ejaculatory and possibly erectile function. Many of the newer minimally invasive therapies appear to preserve sexual function in the short term while sacrificing some of the voiding improvements realized with more complete removal of the prostate adenoma.
Benign prostatic hyperplasia will affect the majority of men at some point in life, and surgical treatment remains an integral option for managing the associated urinary symptoms. These treatments are associated with variable rates of sexual side effects, including ejaculatory, erectile, and orgasmic dysfunction. As the impact of these treatment modalities on sexual dysfunction has become more widely acknowledged, there has been a rise in interest in modalities that minimize adverse sexual side effects. Recent studies have sought to further elucidate the relationship between surgical treatment of benign prostate hyperplasia and sexual outcomes, and a number of studies have demonstrated that treatment of benign prostate hyperplasia can actually result in improved sexual function for some patients. This work intends to review the proposed pathophysiology behind the sexual side effects resulting from the surgical treatment of benign prostate hyperplasia and review the literature regarding both established and emerging surgical techniques.
KeywordsBenign prostatic hyperplasia Lower urinary tract symptoms Erectile dysfunction Sexual function LUTS BPH
Compliance with Ethical Standards
Conflict of Interest
Alex Borchert declares no potential conflicts of interest.
David A Leavitt is a consultant and on the medical advisory board for Boston Scientific Company.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of Particular Interest, Published Recently, Have Been Highlighted as: • Of Importance •• Of Major Importance
- 4.Benjamin Gozalez-Sanchez JC-G, Alejandro Rivera-Ramirez J, Herrera-Caceres JO, Olvera-Posada D, Villeda-Sandoval CI, Castillejos-Molina RA, et al. The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS). World J Urol. 2016;34:979–83.CrossRefGoogle Scholar
- 6.Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell-Walsh Urology. 11th Edn. Elsevier; 2016. P4176.Google Scholar
- 10.Roehrborn CG, McConnell JD, Barry MJ, Benaim E, Bruskewitz RC, Blute ML, Holtgrewe HL, Kaplan SA, Lang JL, Lowe FC, Roberts RG, Stein BS. AUA Guideline on the Management of Benign Prostatic Hyperplasia. 2003.Google Scholar
- 17.Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivizatos G, et al. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int. 2013;112:109–20.CrossRefPubMedGoogle Scholar
- 18.Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller A, Henderson W. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med. 1995;332(2):75–9.Google Scholar
- 24.Bouchier-Hayes DM, van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010;105(7):964–9.CrossRefPubMedGoogle Scholar
- 25.Pereira-Correia JA, de Moraes Sousa KD, Santos JBP, de Morais Perpétuo D, Lopes-da-Silva LF, Krambeck RL, et al. GreenLight HPS 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int. 2012;110(8):1184–9.CrossRefPubMedGoogle Scholar
- 26.• Lukacs B, Loeffler J, Bruyere F, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol. 2012;61:1165–73. Solid, multicenter randomized controlled trial comparing TURP and PVP with attention to the sexual side effects of each treatment, 1173. CrossRefPubMedGoogle Scholar
- 27.• Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066–96. Large meta-analysis comparing outcomes between TURP, HoLEP, PVP. CrossRefPubMedGoogle Scholar
- 32.Elshal AM, el-Assmy A, Mekkawy R, Taha DE, el-Nahas AR, Laymon M, et al. Prospective controlled assessment of men’s sexual function changes following Holmium laser enucleation of the prostate for treatment of benign prostate hyperplasia. Int Urol Nephrol. 2017;49(10):1741–9.CrossRefPubMedGoogle Scholar
- 40.• Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109(3):408–11. Small sample size, but one of the few studies evaluating sexual dysfunction outcomes over a longer time period, 411. CrossRefPubMedGoogle Scholar
- 42.Cimentepe E, Unsal A, Saglam R. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol. 2003;17(2):103–7.Google Scholar
- 43.Frieben RW, Lin HC, Hinh PP, Berardinelli F, Canfield SE, Wang R. The impact of minimally invasie surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl. 2010;12(4):500–8.Google Scholar
- 44.Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004;171: p:2336–40.CrossRefGoogle Scholar
- 45.Francisca EA, d'Ancona FC, Meuleman EJ, DeBruyne FM, de la Rosette JJ. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol. 1999;161:486–90.Google Scholar
- 47.Hoffman RM, Monga M, Elliott SP, Macdonald R, Langsjoen J, Tacklind J, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;12(9):CD004135.Google Scholar
- 48.• Roehrborn C, Barkin J, Gange SN, Giddens JL, Bolton DM, Cowan BE. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24(3):8802–13. 5-year results from prostatic urethral lift, showing the only minimal effect on sexual fucion of this techinque at short-intermediate follow-up. PubMedGoogle Scholar
- 53.• McVary KT, Roehrborn CG. Three-year outcomes of the prospective, randomized controlled Rezum system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. 2018;111:1–9. 3-year results from convective water thermal therapy, showing the only minimal effect on sexual fucion of this techinque at short-term follow-up. CrossRefPubMedGoogle Scholar
- 54.McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195(5):1529–38.CrossRefPubMedGoogle Scholar